Victory Capital Management’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
Victory Capital Management's IPSC Position: Q3 2026 in Review
Victory Capital Management reduced its Century Therapeutics (IPSC) stake by 0.56% in Q3 2026, selling an estimated $162 and leaving 14,022 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #2487.
Victory Capital Management first reported a position in IPSC in Q2 2026 and has held it in 2 quarters since. The position peaked at $34.5K in Q2 2026. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.
- Victory Capital Management held 14,022 shares of Century Therapeutics worth $24K as of Q3 2026.
- Victory Capital Management sold 79 Century Therapeutics shares in Q3 2026, an estimated $162.
- Century Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2487 holding.
- Victory Capital Management first reported a position in Century Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Victory Capital Management's Century Therapeutics position peaked at $34.5K in Q2 2026.
- 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.